Literature DB >> 22205900

Update in cardiology.

Dragos Vinereanu1, Sorina Mihaila.   

Abstract

Year:  2011        PMID： 22205900      PMCID： PMC3239396     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN： 1841-9038


× No keyword cloud information.
  4 in total

1.  Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot).

Authors:  Grzegorz Gajos; Jaroslaw Zalewski; Pawel Rostoff; Jadwiga Nessler; Wieslawa Piwowarska; Anetta Undas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-26       Impact factor: 8.311

2.  Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation.

Authors:  Eli I Lev; Alejandro Solodky; Naama Harel; Aviv Mager; David Brosh; Abid Assali; Milton Roller; Alexander Battler; Neal S Kleiman; Ran Kornowski
Journal:  J Am Coll Cardiol       Date:  2010-01-12       Impact factor: 24.094

3.  Apixaban in patients with atrial fibrillation.

Authors:  Stuart J Connolly; John Eikelboom; Campbell Joyner; Hans-Christoph Diener; Robert Hart; Sergey Golitsyn; Greg Flaker; Alvaro Avezum; Stefan H Hohnloser; Rafael Diaz; Mario Talajic; Jun Zhu; Prem Pais; Andrzej Budaj; Alexander Parkhomenko; Petr Jansky; Patrick Commerford; Ru San Tan; Kui-Hian Sim; Basil S Lewis; Walter Van Mieghem; Gregory Y H Lip; Jae Hyung Kim; Fernando Lanas-Zanetti; Antonio Gonzalez-Hermosillo; Antonio L Dans; Muhammad Munawar; Martin O'Donnell; John Lawrence; Gayle Lewis; Rizwan Afzal; Salim Yusuf
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

4.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.